HOLX Stock Overview
Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 1/6 |
Past Performance | 2/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
My Notes
NewNotes are coming soon
Hologic, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$84.68 |
52 Week High | US$85.31 |
52 Week Low | US$59.78 |
Beta | 1.02 |
1 Month Change | 8.80% |
3 Month Change | 13.89% |
1 Year Change | 13.30% |
3 Year Change | 59.26% |
5 Year Change | 124.32% |
Change since IPO | 3,442.17% |
Recent News & Updates
Recent updates
Hologic (NASDAQ:HOLX) Seems To Use Debt Quite Sensibly
Jan 18Is Now The Time To Look At Buying Hologic, Inc. (NASDAQ:HOLX)?
Jan 03Shareholders Would Enjoy A Repeat Of Hologic's (NASDAQ:HOLX) Recent Growth In Returns
Dec 02Hologic (NASDAQ:HOLX) Seems To Use Debt Quite Sensibly
Oct 12Is Hologic, Inc. (NASDAQ:HOLX) Potentially Undervalued?
Sep 27Hologic announces $1B share buyback program
Sep 26We Like Hologic's (NASDAQ:HOLX) Returns And Here's How They're Trending
Aug 27Hologic cut to Neutral at BTIG on macro concerns
Jul 18We Think Hologic (NASDAQ:HOLX) Can Stay On Top Of Its Debt
Jul 11Is Hologic, Inc. (NASDAQ:HOLX) Potentially Undervalued?
Jun 28Are Investors Undervaluing Hologic, Inc. (NASDAQ:HOLX) By 41%?
Jun 15Hologic: Unfairly Punished, Or Not? Examination Of Cash Flow And Earnings
Jun 03Returns on Capital Paint A Bright Future For Hologic (NASDAQ:HOLX)
May 09Is Hologic (NASDAQ:HOLX) Using Too Much Debt?
Apr 12Is It Time To Consider Buying Hologic, Inc. (NASDAQ:HOLX)?
Mar 30A Look At The Intrinsic Value Of Hologic, Inc. (NASDAQ:HOLX)
Mar 17We Think Hologic, Inc.'s (NASDAQ:HOLX) CEO Compensation Looks Fair
Mar 04Hologic's Underperformance Makes This A Name Worth Further Consideration
Feb 17Is Hologic (NASDAQ:HOLX) A Risky Investment?
Jan 02What Is Hologic, Inc.'s (NASDAQ:HOLX) Share Price Doing?
Dec 20Is There An Opportunity With Hologic, Inc.'s (NASDAQ:HOLX) 29% Undervaluation?
Dec 07Hologic: Still Going Strong
Nov 28If You Like EPS Growth Then Check Out Hologic (NASDAQ:HOLX) Before It's Too Late
Oct 20Is Hologic (NASDAQ:HOLX) Using Too Much Debt?
Sep 23Hologic: An Undervalued Leader
Sep 23Is Now An Opportune Moment To Examine Hologic, Inc. (NASDAQ:HOLX)?
Sep 10Is There An Opportunity With Hologic, Inc.'s (NASDAQ:HOLX) 25% Undervaluation?
Aug 26Hologic: Prepare For Takeoff
Jul 29Do Hologic's (NASDAQ:HOLX) Earnings Warrant Your Attention?
Jul 18Is Hologic (NASDAQ:HOLX) Using Too Much Debt?
Jun 21Is Hologic, Inc. (NASDAQ:HOLX) Potentially Undervalued?
Jun 08Estimating The Fair Value Of Hologic, Inc. (NASDAQ:HOLX)
May 26Hologic falls on Q2 earnings miss and worse-than-expected guidance
Apr 28Hologic (NASDAQ:HOLX) Could Easily Take On More Debt
Mar 14Shareholder Returns
HOLX | US Medical Equipment | US Market | |
---|---|---|---|
7D | 2.3% | 3.8% | 1.7% |
1Y | 13.3% | -9.3% | -9.6% |
Return vs Industry: HOLX exceeded the US Medical Equipment industry which returned -9.3% over the past year.
Return vs Market: HOLX exceeded the US Market which returned -9.6% over the past year.
Price Volatility
HOLX volatility | |
---|---|
HOLX Average Weekly Movement | 3.0% |
Medical Equipment Industry Average Movement | 8.5% |
Market Average Movement | 6.7% |
10% most volatile stocks in US Market | 17.5% |
10% least volatile stocks in US Market | 2.8% |
Stable Share Price: HOLX is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 3% a week.
Volatility Over Time: HOLX's weekly volatility (3%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1985 | 6,944 | Steve MacMillan | https://www.hologic.com |
Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalovirus; Aptima BV and Aptima CV/TV assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth.
Hologic, Inc. Fundamentals Summary
HOLX fundamental statistics | |
---|---|
Market Cap | US$20.88b |
Earnings (TTM) | US$990.20m |
Revenue (TTM) | US$4.47b |
21.1x
P/E Ratio4.7x
P/S RatioIs HOLX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
HOLX income statement (TTM) | |
---|---|
Revenue | US$4.47b |
Cost of Revenue | US$1.54b |
Gross Profit | US$2.92b |
Other Expenses | US$1.93b |
Earnings | US$990.20m |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
n/a
Earnings per share (EPS) | 4.02 |
Gross Margin | 65.45% |
Net Profit Margin | 22.17% |
Debt/Equity Ratio | 55.5% |
How did HOLX perform over the long term?
See historical performance and comparison